非小细胞肺癌肺叶切除术、肺段切除术与楔形切除术后的生存率比较
该研究基于监测、流行病学和最终结果数据库,比较第八版TNM分期IA期非小细胞肺癌患者接受肺叶切除术、肺段切除术与楔形切除术后的生存率。共纳入16,819例患者,采用Cox回归模型和倾向性匹配分析,按肿瘤大小比较三组的总生存率和肺癌特异性生存率。
要点
- 肿瘤≤1.0 cm时,肺叶切除与楔形切除的总生存率有差异,但三组肺癌特异性生存率无统计学差异。
- 肿瘤1.1–2.0 cm时,肺叶切除与肺段切除的肺癌特异性生存率无统计学差异,但两者总生存率和肺癌特异性生存率均优于楔形切除。
- 肿瘤2.1–3.0 cm时,肺叶切除的总生存率和肺癌特异性生存率优于肺段切除或楔形切除,而肺段切除与楔形切除相似。
核心结论
- 对于≤1.0 cm的IA期非小细胞肺癌,肺叶切除、肺段切除和楔形切除是肿瘤学上相当的术式。
- 对于1.1–2.0 cm的肿瘤,肺叶切除和肺段切除可达到等效的生存率,但两者生存率均优于楔形切除。
- 对于2.1–3.0 cm的肿瘤,肺叶切除仍是标准手术方式;对于不适合肺叶切除的患者,肺段切除和楔形切除显示相似的生存率。
研究设计与样本
- 研究从监测、流行病学和最终结果数据库识别接受肺叶切除、肺段切除或楔形切除的IA期非小细胞肺癌患者。
- 采用Cox回归模型和倾向性匹配分析,按肿瘤大小比较三组的总生存率和肺癌特异性生存率。
- 共16,819例患者符合标准。
主要发现
- 肿瘤≤1.0 cm时,肺叶切除的总生存率优于楔形切除,但三组肺癌特异性生存率无统计学差异。
- 肿瘤1.1–2.0 cm时,肺叶切除与肺段切除的肺癌特异性生存率无统计学差异,但两者总生存率和肺癌特异性生存率均优于楔形切除。
- 肿瘤2.1–3.0 cm时,肺叶切除的总生存率和肺癌特异性生存率优于肺段切除或楔形切除,而肺段切除与楔形切除相似。
临床怎么用
- 对于≤1.0 cm的IA期非小细胞肺癌,肺叶切除、肺段切除和楔形切除均为可比的肿瘤学术式。
- 对于1.1–2.0 cm的肿瘤,肺叶切除和肺段切除可带来等效生存率,且优于楔形切除。
- 对于2.1–3.0 cm的肿瘤,肺叶切除仍是标准手术方式;不适合肺叶切除者,肺段切除与楔形切除生存率相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to compare the survival rates after lobectomy, segmentectomy, and wedge resection for the eighth edition of the tumor, node, metastasis classification for stage IA non-small cell lung cancer (NSCLC). METHODS: Patients who underwent lobectomy, segmentectomy, or wedge resection for stage IA NSCLC were identified from the Surveillance, Epidemiology, and End Results database. A Cox regression model and propensity-matched analysis were used. The overall survival (OS) rates and lung cancer-specific survival (LCSS) rates among the three groups were compared by tumor size. RESULTS: A total of 16,819 patients met our criteria. Although the OS rate was better for lobectomy than for wedge resection, no statistical differences in the LCSS rate were identified among the three treatment groups of patients with tumors that were 1.0 cm or smaller. For tumors from 1.1 to 2.0 cm, lobectomy and segmentectomy showed no statistical differences in the LCSS rate, but both conferred better OS and LCSS rates than wedge resection. For tumors from 2.1 to 3.0 cm, the OS and LCSS rates were better for lobectomy than for segmentectomy or wedge resection, but similar for segmentectomy and wedge resection. CONCLUSIONS: Lobectomy, segmentectomy, and wedge resection are comparable oncologic procedures for patients with stage IA NSCLC that is 1.0 cm or smaller. For tumors from 1.1 to 2.0 cm, lobectomy and segmentectomy could lead to equivalent survival rates but showed better survival rates than that observed with wedge resection. For tumors from 2.1 to 3.0 cm, lobectomy is still the standard surgical procedure; for patients who are unsuitable candidates for lobectomy, segmentectomy and wedge resection show similar survival rates.
引用
- Cao J, Yuan P, Wang Y, et al. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018. PMID: 29462591. doi:10.1016/j.athoracsur.2018.01.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。